Roland Magnusson/iStock Editorial via Getty Images AstraZeneca (NASDAQ:AZN) posted around 5% Y/Y higher revenues to $11.5B for Q3, missing consensus estimates. The top-line was weighed
Tag: drug
selvanegra/iStock by means of Getty Pictures Biogen (NASDAQ:BIIB) stocks spiked Wednesday, rallying different Alzheimer’s drug builders after the corporate and its spouse Eisai (OTCPK:ESALY) (OTCPK:ESALF)
yuelan Johnson & Johnson (NYSE:JNJ) on Wednesday stated that its esketamine nasal spray Spravato confirmed awesome efficacy in comparison to quetiapine extended-release (XR) in adults